EP2358327A1 - Verbindungsvorrichtung - Google Patents

Verbindungsvorrichtung

Info

Publication number
EP2358327A1
EP2358327A1 EP20080875455 EP08875455A EP2358327A1 EP 2358327 A1 EP2358327 A1 EP 2358327A1 EP 20080875455 EP20080875455 EP 20080875455 EP 08875455 A EP08875455 A EP 08875455A EP 2358327 A1 EP2358327 A1 EP 2358327A1
Authority
EP
European Patent Office
Prior art keywords
pressure
connector device
fluid
check valve
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP20080875455
Other languages
English (en)
French (fr)
Other versions
EP2358327B1 (de
Inventor
Håkan TÖRNQVIST
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carmel Pharma AB
Original Assignee
Carmel Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carmel Pharma AB filed Critical Carmel Pharma AB
Publication of EP2358327A1 publication Critical patent/EP2358327A1/de
Application granted granted Critical
Publication of EP2358327B1 publication Critical patent/EP2358327B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096Combination of a vial and a syringe for transferring or mixing their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/201Piercing means having one piercing end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2037Separating means having valve means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2068Venting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2079Filtering means
    • A61J1/2082Filtering means for gas filtration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2079Filtering means
    • A61J1/2086Filtering means for fluid filtration

Definitions

  • the present invention relates to a connector device for connecting a first and a second fluid container.
  • the connector device has an improved valve arrangement which permits fluid flow in two different directions.
  • the substance consists of cytotoxic drugs, radio-labelled or allergy-inducing substances it is for safety reasons important that the transfer of such substances from the vial to a patient, possibly by way of an infusion bag, takes place under satisfactory conditions and also so that an air contamination imparted by the injection needle during the transfer is avoided.
  • the bottle connector comprises a neck element to which an injector can be fixedly coupled, and second connection means to connect the bottle connector to the drug bottle.
  • the connector has a hollow needle to penetrate a closure on the bottle.
  • a fluid transfer channel is arranged within the hollow needle.
  • the bottle connector further comprises a pressure compensating means comprising a flexible container and a gas channel within the hollow needle for transporting gas from the bottle to the flexible container or vice versa in order to allow fluid to be transferred via the fluid transfer channel.
  • the gas channej includes a filter to prevent liquid passage into said flexible container as this may damage the flexible container.
  • one drawback is that the filter can be blocked If the filter is blocked, the function of the flexible container is reduced and the pressure inside the bottle can instantly increase or decrease to levels which could cause difficulties with respect to handling
  • pressure increases or decreases inside the bottle can be hazardous, since in theory, it could lead to an increased risk of leakage It therefore seems to be a need for additional improvements in this field
  • the vial adaptor has a housing, an expandable chamber, a filter to prevent fluid from entering the expandable chamber A check valve is arranged in the proximity of the filter to enable a one way fluid flow
  • the connector is however not very flexible in terms of handling nor does it provide any means by which the filter can be prevented form being obstructed, i e clogged
  • the teaching of the publication is further 15 that it is preferable that the check valve has as low cracking pressure as possible
  • the above mentioned drawbacks are at least partly solved by means of a connector device according to the present invention More precisely they are solved by a connector 0 device for establishing fluid communication after connecting with a first fluid container and a second fluid container
  • the connector device comprises a housing which in turn comprises first connection means having a pierceable barrier member to connect the first fluid container, and second connection means, to connect the second fluid container, and a fluid transfer channel to enable fluid communication between the first and second fluid 5 containers after assembly
  • the housing further comprises at least one pressure normalization channel arranged to normalize the pressure in the second fluid container during fluid transfer
  • the at least one pressure normalization channel has an outlet opening, an inlet opening, a barrier filter and at least one valve arrangement 0
  • the at least one valve arrangement is arranged to permit fluid to flow in a first and a second direction wherein the first direction is in a direction from the inlet opening towards the outlet opening and the second direction is from the outlet opening towards the inlet opening Furthermore, the at least one valve arrangement has a cracking pressure in the first direction
  • the first check valve and its cracking pressure enable a build up of pressure in the pressure normalization channel which partly prevents fluid from the second fluid container to reach the barrier filter during administration if the assembly for instance is; shaken; held up side down; laid down on the side or; when an excessive amount of medicaments and possibly air are returned to the second fluid container.
  • the at least one valve arrangement comprises a first and a second check valve to enable the fluid flow in the first and the second direction.
  • the first and the second check valve are preferably arranged in opposite directions and/or substantially parallel of each other.
  • the main function is however that the first and the second check valve enable a fluid flow in the first and the second direction.
  • the cracking pressure of the first check valve is at least 0,04 atm, preferably between 0,04 - 0,5 atm.
  • the cracking pressure of 0,04 atm is enough to provide for the clogging preventing function while at the same time not impart a cracking pressure which makes the handling uncomfortable or difficult for a user, when the user is administrating or retracting medicament from the second fluid container. It has been found that a to high cracking pressure can cause a user to use an excessive amount of force during which other accidents can occur such as the device can slip from the users hands.
  • the second check valve has a cracking pressure in the second direction of less than 0,5 atm, preferably less than 0,25 atm, even more preferably less than 0,1 atm and most preferred of less than 0,02 atm It may optionally be between 0,02- 0,5 atm, 0,02-0,25 atm or 0,02-0,1 atm
  • the at least one valve arrangement comprises a membrane having at least one slit Such a membrane provides for a cracking pressure in both the first and the second direction
  • an expandable bladder is arranged at the outlet opening of the at least one pressure normalization channel and in communication with the at least one pressure normalization channel As such, gas which has passed through the barrier filter is not exposed to the environment but collected in the volume defined by the expandable bladder
  • the expandable bladder is preferably connected with a parabolic formed disc
  • the volume of the pressure normalization channel between the first check valve and the inlet opening of the pressure normalization channel is preferably relatively small
  • the volume can be ⁇ 1 ml, preferably between 0,01 ml - 0,9 ml This enables a pressure build up inside the pressure normalization channel which effectively prevents parts of the fluid from reaching the barrier filter which thereby could cause clogging of the filter
  • the present invention relates to a connector device to connect a first and a second fluid container, directly or indirectly
  • the connector device exhibit a first and a second connection means, a pierceable barrier member, a piercing member, a fluid transfer channel and a pressure normalization channel
  • the pressure normalization channel is arranged to normalize an increasing pressure inside second fluid container
  • a valve arrangement permitting fluid to flow in a first and a second direction is arranged in the pressure normalization channel
  • the valve arrangement exhibit a cracking pressure in at least the first direction
  • the present invention provides for a connector device which reduces the risk of clogging the barrier filter
  • the present invention can be said to provide a fluid barrier to the barrier filter by means of the check valve arrangement and preferably the first and the second check valve
  • the check valve arrangement provides directly for a hurdle, but also indirectly due to the pressure build up in the fluid transfer channel, for the fluid while permitting gas to pass the check valve arrangement and at the same time permit gas and fluid to flow in both the first and the second direction
  • the present invention also relates to a valve arrangement, as described above, for a medical device, preferably a connector device, having a fluid flow channel with an inlet opening and an outlet opening, such as a pressure normalization channel for reducing a pressure build up in a connected fluid container
  • the valve arrangement comprises a first and a second check valve arranged in parallel with each other so that after assembly to the fluid flow channel, the valve arrangement is arranged to permit fluid to flow in a first and a second direction, wherein the first direction is in a direction from the inlet opening towards the outlet opening and the second direction is from the outlet opening towards the inlet opening, wherein at least the first check valve has a cracking pressure
  • Both the first and the second check valves can be provided with a cracking pressure
  • the valve arrangement is further described with reference to figures 1-5 below
  • figure 1 shows a cross section of an embodiment of the connector device according to the present invention
  • figure 2 shows a cross section of the connector device shown in figure 1 in which the expandable bladder is shown in its expanded state, i e filled with gas
  • figure 3 shows a close up of the valve arrangement comprising a first and a second check valve as shown in figure 1 and 2
  • figure 4 shows parts of a first fluid container connected to a piercing member protection device, which in turn is connected to the connector device, according to the present invention, and as shown in figure 1 and 2, which in turn is connected to a second fluid container, to establish a fluid communication there between
  • figure 5a-5b shows the connector device shown in figures 1-4, as seen in perspective with expandable bladder in its un-expanded state respectively in its expanded state
  • Figure 1 shows in a cross sectional view a connector device 10 for establishing fluid communication between a first container and a second container, according to one embodiment of the present invention
  • the connector device 10 has a housing 1 1 to which a first and a second connection means 12, 13 are arranged
  • the first connection means 12 is substantially formed by a neck element 14 having a first and a second guiding groove 15, 16 arranged therein
  • the first and the second guiding groove 15, 16 is arranged to guide corresponding guiding protrusions on e g a piercing member protection device arranged to a first fluid container as shown in figure 4, to establish a firm attachment to the connector device 10 after which fluid communication can be established
  • the first connection means 12 is formed integrally with the housing 1 1
  • One type of connection means 12 which can be used on the connector device 10 is disclosed in the patent publication US 6,715,520 B2 which also discloses a piercing member protection device and an appropriate first fluid container connected thereto
  • the second connection means 13 which is arranged at substantially the opposite end of the housing 1 1 of the connector device 10 and with respect to the first connection means 12, comprises a plurality of engaging hook elements 20
  • Each hook element 20 comprises a flexible tongue 21 having a distal and a proximal end 22, 23 The proximal end exhibits a hook protrusion 24 arranged to engage a corresponding flange on the second container, as is shown in greater detail in figure 4
  • One example of appropriate hook elements 20 and a coupling arrangement in the form of a neck element, for the hook elements 20 are disclosed in the patent publication of US 6,715,520 B2
  • a fluid transfer channel 30 extends substantially between the first and the second connection means 12, 13
  • the purpose of the fluid transfer channel 30 is to permit e g a needle to extend through the housing 11 of the connector device 10 and to thereby permit fluid to be transferred through the connector device 10
  • the fluid transfer channel has a longitudinal direction with a first and a second end 31 , 32
  • a pierceable barrier member 40 is arranged in the proximity of the first connection means 12 and at the first end 31 of the fluid transfer channel 30
  • the pierceable barrier member 40 provides for a liquid and gas tight seal between a piercing member and the pierceable barrier member 40 during fluid transfer so to minimize leakage and thereby exposure of hazardous medicaments to a user
  • a piercing member 50 Protruding out from the housing 11 is a piercing member 50
  • the piercing member 50 has a proximal end 51 and a distal end 52
  • the fluid transfer channel 30 extends inside of the piercing member 50 in this embodiment
  • the proximal end 51 of the piercing member 50 is arranged in the proximity of the pierceable barrier member 40 and is supported by a supporting wall structure 41 of the housing 11
  • the piercing member 50 extends in a direction substantially parallel with the plurality of hook elements 20 and serves the purpose of piercing the second fluid container during assembly, as is shown in greater detail in figure 3
  • the second end 32 of the fluid transfer channel 30 is substantially at the distal end 52 of the piercing member 50, with the exception of a piercing tip 53 which extends slightly longer
  • a pressure normalization channel 60 extends from the distal end 52 of the piercing member 50 and substantially parallel with the fluid transfer channel 30 inside the piercing member 50 Substantially at the supporting wall structure 41 of the housing 11 , the pressure normalization channel 60 diverts in a direction perpendicular to the fluid transfer channel 30
  • the pressure normalization channel 60 has an inlet opening 61 arranged substantially at the distal end 52 of the piercing member 50 and an outlet opening 62
  • the outlet opening 62 is furthermore positioned substantially at the centre of a parabolic disc 63 having an expandable bladder 64 In figure 1 the expandable bladder 64 is in its unexpanded state
  • Figure 2 shows the connector device 10 shown in figure 1 but with the difference that the expandable bladder 64 is shown in its expanded state
  • the pressure normalization channel 60 comprises a barrier filter 70 arranged to cover the outlet opening 62 of the pressure normalization channel 60
  • the barrier filter 70 serves the purpose of preventing any fluid from reaching the expandable bladder 64 and the volume defined by the parabolic disc 63 and the expandable bladder 64
  • the barrier filter 70 is preferably a hydrophobic filter which permits gas to pass but prevents liquid to pass Filters like the barrier filter 70 are know per se and will need no further description herein
  • a valve arrangement 80 is positioned to intersect the fluid flow of the pressure normalization channel 60 In figure 1 and 2, and in one embodiment according of the present invention, the valve arrangement 80 is positioned in the proximity of the outlet opening 62 of the pressure normalization channel 60
  • the main purpose of the valve arrangement 80 is to prevent clogging of the filter barrier 70 by providing a cracking pressure to the valve arrangement 80 for the fluid which flows in a direction from the inlet opening 61 to the outlet opening 62 of the pressure normalization channel 60 while permitting preferably a minimal cracking pressure in the opposite direction
  • Figure 3 shows a part of the connector device 10 seen in greater detail More specifically, figure 3 shows part of the pressure normalization channel 60, the outlet opening 62 of the pressure normalization channel 60, parts of the supporting wall structure 41 , parts of the parabolic disc 63 and parts of the expandable bladder 64, the barrier filter 70 and the valve arrangement 80
  • the valve arrangement 80 comprises a first and a second check valve 81 , 82
  • valve arrangement 80 is positioned to snugly fit inside the pressure normalization channel 60 as a separate component This is done for manufacturing reasons, although it is possible that the valve arrangement 80 and the first and the second check valves 81 , 82 are integrated parts of the housing 11
  • the valve arrangement 80 comprises a substantially cylindrical housing 83 with a longitudinal centre line A and a transverse centre line B
  • the cylindrical housing 83 exhibits a first and a second end 84, 85 and an inner and outer surface 86, 87
  • the outer surface 87 of the cylindrical housing 83 is positioned towards an inner surface 65 of the pressure normalization channel 60 so as to provide for a liquid and gas tight seal there between
  • the outer surface 87 of the cylindrical housing 83 is further provided with a slightly tilting surface 88, which tilts towards the longitudinal centre line A of the cylindrical housing 83 so that a substantially wedge-like form is provided at least at the first end 84 of the cylindrical housing 83
  • the inner surface 65 of the pressure normalization channel 60 is likewise tilted in a direction towards the longitudinal centre line A of cylindrical housing 83, to provide for a substantially funnel-like form and to receive the tilting surface 88 of the cylindrical housing 83
  • the tilting surfaces provides for a secure attachment of the valve arrangement 80 to the pressure normalization channel 60
  • the inner surface 65 of the pressure normalization channel 60 can further be provided with a recess 66 to receive the cylindrical housing 83 so that the inner surface 86 of the cylindrical housing 83 is aligned with the inside of the pressure normalization channel 60 which provides for a smooth transition there between
  • the first and the second check valves 81 , 82 can be of any conventional type although some preferred are listen below
  • the first and the second check valve 81 ,82 can be a ball check valve, in which the disc, the movable part to block the flow, is a spherical ball
  • the ball can be spring-loaded to help keep it shut In the case of no spring load on the ball, reverse flow is required to move the ball towards the seat and create a seal
  • the interior surface of the main seats of the ball check valves are more or less conically-tapered to guide the ball into the seat and form a positive seal when stopping reverse flow
  • the ball can be replaced by a poppet energized by a spring
  • the first and the second check valves 81 , 82 can optionally be a diaphragm check valve
  • a diaphragm check valve Such check valve uses a flexing rubber diaphragm positioned to create a normally-closed valve Pressure on the upstream side must be greater than the pressure on the downstream side by a certain amount, known as the pressure differential, for the check valve to open allowing flow Once positive pressure stops, the diaphragm automatically flexes back to its original closed position
  • a swing check valve is a butterfly-style check valve in which a disc, the movable part to block the flow, swings on a hinge or trunnion, either onto the seat to block reverse flow or off the seat to allow forward flow
  • the seat opening cross-section may be perpendicular to the centerline between the two ports or at an angle
  • a clapper valve be used having a hinged gate, preferably with a biasing spring to urge it shut
  • lift check valves can be used Combinations of the above mentioned check valves are of course also possible
  • the first and the second check valves 81 , 82 can optionally be replaced by a membrane having at least one slit This embodiment is however less preferable
  • FIG 4 shows the connector device 10 shown in figures 1-3
  • the connector device 10 is assembled via its first connection means 11 to a piercing member protection device 5, which in turn can be connected to a first fluid container 1 , e g a syringe, and via its second connection means 12 with a second fluid container 2
  • a first fluid container 1 e g a syringe
  • second connection means 12 with a second fluid container 2
  • the distal end 52 and especially the piercing tip 53 of the piercing member 50 is pierced through a septum 3 arranged to cover the opening of the second fluid container 2
  • the hook elements 20 fixedly connects the connector device 10 as the flexible tongues 21 having hook protrusions 24 engages the corresponding flange 4 on the second fluid container 2
  • a user is enabled to insert fluid into the second container 2, or optionally to retract fluid
  • the first check valve 81 has a cracking pressure, in the shown embodiment, of about 0,04 atm
  • a relatively high counter pressure is quickly built up in the pressure normalization channel 60 between the inlet opening 61 and the first check valve 81
  • the relatively high counter pressure efficiently reduces the amount of medicament which reaches the barrier filter 70 and thereby significantly reduces the risk of clogging the barrier filter 70 While at the same time, the cracking pressure of the first check valve 81 is low enough not to cause any inconvenience
  • each check valve 81 , 82 By having a first and a second check valve 81 , 82 the cracking pressures of each check valve 81 , 82 can be customized, permitting a very flexible valve arrangement 80 which can be fitted to any connector device, independently of the size of the pressure normalization channel used for that specific connecter device
  • the pressure normalization channel can comprise two individual channels in which the first check valve 81 is positioned in one channel and the second check valve 82 is positioned in another channel
  • the two individual channels can have mutual inlet and openings
  • Figure 5a-5b shows the connector device as shown in figures 1 -4
  • Figure 5a shows the expandable bladder 64 before expansion
  • figure 5b shows the expandable bladder after expansion, i e being filled with gas
  • the first connection means 12 and the second connection means 13 is seen as being formed as an integrated part of the housing 1 1 of the connector device 10
  • the hook elements 20 having the flexible tongues
  • the pressure normalization channel 60 is in communication with the volume defined by the expandable bladder 64 and any fluid container connected to the connector device 10 by means of the second connection means 13
  • the second fluid container 2 has a total volume of 120 ml (V tot ) but is only filled with 100 ml of a cytotoxic liquid (V
  • 30 ml is intended to be aspired although 32 ml of liquid is actually aspired from the second fluid container 2, leaving 52 ml of gas inside the second container 2 Alternatively some air bubbles are aspired into the syringe so that for example 0,5 ml or air is inside the syringe and 51 ,5 ml is inside the second container 2
  • the height of the liquid column is assumed in this case to be about 50 mm (although different diameter of the second fluid container would give a different liquid column), hence, p + p - p

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
EP20080875455 2008-12-15 2008-12-15 Verbindungsvorrichtung Active EP2358327B1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2008/067522 WO2010069359A1 (en) 2008-12-15 2008-12-15 Connector device

Publications (2)

Publication Number Publication Date
EP2358327A1 true EP2358327A1 (de) 2011-08-24
EP2358327B1 EP2358327B1 (de) 2013-11-20

Family

ID=40934961

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20080875455 Active EP2358327B1 (de) 2008-12-15 2008-12-15 Verbindungsvorrichtung

Country Status (6)

Country Link
EP (1) EP2358327B1 (de)
JP (1) JP5457462B2 (de)
CN (1) CN102307556B (de)
CA (1) CA2747024C (de)
ES (1) ES2447303T3 (de)
WO (1) WO2010069359A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7547300B2 (en) 2006-04-12 2009-06-16 Icu Medical, Inc. Vial adaptor for regulating pressure
WO2010022095A1 (en) 2008-08-20 2010-02-25 Icu Medical, Inc. Anti-reflux vial adaptors
WO2010099000A2 (en) * 2009-02-24 2010-09-02 Teva Medical Ltd. Vial adapter assembly in drug mixing system
JP5716037B2 (ja) 2009-11-20 2015-05-13 カルメル ファルマ アクチボラゲット 医療器具コネクタ
ES2934668T3 (es) 2011-08-18 2023-02-23 Icu Medical Inc Adaptadores de vial de regulación de presión
CA2860589C (en) 2012-01-13 2021-10-26 Icu Medical, Inc. Pressure-regulating vial adaptors and methods
CN104244905B (zh) * 2012-03-01 2019-06-04 贝克顿迪金森有限公司 压力平衡装置和储器
WO2013142618A1 (en) 2012-03-22 2013-09-26 Icu Medical, Inc. Pressure-regulating vial adaptors
WO2014003614A1 (en) * 2012-06-27 2014-01-03 Carmel Pharma Ab Medical connecting device
US9089474B2 (en) * 2012-07-13 2015-07-28 Becton Dickinson and Company Ltd. Medical vial access device with pressure equalization and closed drug transfer system and method utilizing same
JP6222512B2 (ja) 2012-10-16 2017-11-01 株式会社ジェイ・エム・エス 穿刺針アダプタ
US9089475B2 (en) 2013-01-23 2015-07-28 Icu Medical, Inc. Pressure-regulating vial adaptors
EP2948125B1 (de) 2013-01-23 2019-05-22 ICU Medical, Inc. Druckregelungsadapter für eine phiole
WO2015009746A2 (en) 2013-07-19 2015-01-22 Icu Medical, Inc. Pressure-regulating fluid transfer systems and methods
CN103432000A (zh) * 2013-09-10 2013-12-11 吴彩芳 一种自动配药器
EP2893916B1 (de) 2014-01-14 2016-04-13 Tim Plastik ve Kalip Teknolojileri Endustri ve Tic. A.S. Flüssigkeitsübertragungsvorrichtung mit durchstechelement
MX2016009868A (es) * 2014-02-07 2016-10-31 Borla Ind Dispositivo de acceso para recipientes de sustancias fluidificables.
AU2015277135B2 (en) 2014-06-20 2020-02-20 Icu Medical, Inc. Pressure-regulating vial adaptors
CN104337523B (zh) * 2014-10-24 2016-06-01 吴燕霞 能自动抽吸的注射器
US10292904B2 (en) 2016-01-29 2019-05-21 Icu Medical, Inc. Pressure-regulating vial adaptors
EP3518860A4 (de) 2016-09-30 2020-06-10 ICU Medical, Inc. Vorrichtungen und verfahren für zugriff auf druckregelnde phiole
SG11201908927TA (en) * 2017-04-03 2019-10-30 Daiwa Can Co Ltd Connection equipment and equipment connector
JP7086197B2 (ja) * 2018-01-04 2022-06-17 エルカム メディカル エー.シー.エー.エル 閉じた流体移送系のためのバイアルアダプターアセンブリー
CN109998918A (zh) * 2019-04-26 2019-07-12 台州安融医疗器械有限公司 一种配药器
EP4243758A1 (de) * 2020-11-10 2023-09-20 Becton, Dickinson and Company Phiolenadapter mit luftverwaltungsvorrichtung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4372310B2 (ja) * 2000-04-10 2009-11-25 ニプロ株式会社 混注用アダプター
SE517084C2 (sv) * 2000-08-10 2002-04-09 Carmel Pharma Ab Förfarande och anordningar vid aseptisk beredning
US6715520B2 (en) * 2001-10-11 2004-04-06 Carmel Pharma Ab Method and assembly for fluid transfer
JP2007511295A (ja) * 2003-11-14 2007-05-10 メディカル・インスティル・テクノロジーズ・インコーポレイテッド 注入装置及び注入方法
EP1951344B1 (de) * 2005-11-07 2014-05-28 Industrie Borla SpA Sicher zu bedienender, belüfteter phiolenadapter
WO2007148708A1 (ja) * 2006-06-19 2007-12-27 Nipro Corporation 薬液調製用キット

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2010069359A1 *

Also Published As

Publication number Publication date
JP2012511940A (ja) 2012-05-31
EP2358327B1 (de) 2013-11-20
WO2010069359A1 (en) 2010-06-24
JP5457462B2 (ja) 2014-04-02
CN102307556B (zh) 2014-09-03
CA2747024A1 (en) 2010-06-24
ES2447303T3 (es) 2014-03-11
CA2747024C (en) 2016-05-10
CN102307556A (zh) 2012-01-04

Similar Documents

Publication Publication Date Title
US8523838B2 (en) Connector device
CA2747024C (en) Connector device
US10987277B2 (en) Pressure-regulating vial adaptors
EP1492590B1 (de) Vorrichtung zum mischen von medizinischen flüssigkeiten
JP7356487B2 (ja) 単一または複数の容器のための貯留デバイス
ES2371504T3 (es) Conector tipo luer macho autosellante con el tapón de la válvula desviado.
EP1957028B1 (de) Nadelloses zusatzstoff-kontrollventil
EP2036529B1 (de) Kit zur zubereitung eines flüssigen medikaments
ES2949069T3 (es) Sistema de conexión para componentes de dispositivos médicos
JP5095727B2 (ja) 通気式注入アクセス装置
WO2010138357A2 (en) Apparatus and methods for administration of reconstituted medicament
US20220133594A1 (en) Transfer device for use with infusion liquid container

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110614

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20130607

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 641130

Country of ref document: AT

Kind code of ref document: T

Effective date: 20131215

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602008028934

Country of ref document: DE

Effective date: 20140116

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2447303

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20140311

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20131120

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 641130

Country of ref document: AT

Kind code of ref document: T

Effective date: 20131120

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140320

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140220

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140320

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602008028934

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

26N No opposition filed

Effective date: 20140821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20131231

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20131231

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602008028934

Country of ref document: DE

Effective date: 20140821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20081215

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20131215

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20131120

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131120

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140221

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20221122

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231124

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20231121

Year of fee payment: 16

Ref country code: IE

Payment date: 20231123

Year of fee payment: 16

Ref country code: FR

Payment date: 20231122

Year of fee payment: 16

Ref country code: DE

Payment date: 20231121

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240102

Year of fee payment: 16